{"id":50753,"date":"2023-09-20T09:12:31","date_gmt":"2023-09-20T09:12:31","guid":{"rendered":"https:\/\/medsname.com\/pioglit-mf-forte\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"pioglit-mf-forte","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/pioglit-mf-forte\/","title":{"rendered":"Pioglit Mf Forte"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Pioglit MF Forte?<\/h3>\n<p style=\"margin:0;\"><strong>Pioglit MF Forte<\/strong> este un comprimat cu doz\u0103 fix\u0103 combinat\u0103 de <strong>pioglitazon\u0103 (15 mg)<\/strong> \u0219i <strong>metformin\u0103 (850 mg)<\/strong> timp de <strong>diabetului de tip 2<\/strong>. Combin\u0103 dou\u0103 mecanisme de sensibilizare la insulin\u0103: metformina reduce produc\u021bia hepatic\u0103 de glucoz\u0103, iar pioglitazona activeaz\u0103 PPAR-\u03b3 pentru a reduce rezisten\u021ba periferic\u0103 la insulin\u0103. Sc\u0103dere a\u0219teptat\u0103 a HbA1c: <strong>1,5\u20132,0 puncte<\/strong>. <strong>F\u0103r\u0103 hipoglicemie<\/strong> c\u00e2nd este utilizat singur (niciun component nu stimuleaz\u0103 eliberarea de insulin\u0103). Doza tipic\u0103: o tablet\u0103 de dou\u0103 ori pe zi la mese. Principalele compromisuri: cre\u0219terea \u00een greutate (2\u20134 kg), reten\u021bie de lichide \u0219i edem, precum \u0219i tulbur\u0103ri gastrointestinale obi\u0219nuite ale metforminei \u00een primele dou\u0103 s\u0103pt\u0103m\u00e2ni. Evita\u021bi \u00een insuficien\u021b\u0103 cardiac\u0103, eGFR &lt; 30, cancer vezical activ \u0219i afec\u021biuni hepatice severe.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Pioglit MF Forte?<\/h2>\n<p>Pioglit MF Forte este un comprimat antidiabetic oral cu doz\u0103 fix\u0103 care con\u021bine <strong>pioglitazon\u0103 (15 mg)<\/strong> \u0219i <strong>clorhidrat de metformin\u0103 (850 mg)<\/strong>, fabricat de Sun Pharma. Disponibil \u00een cutii cu 30, 60, 90 sau 180 de comprimate. Este utilizat la adul\u021bii cu diabet zaharat de tip 2 c\u00e2nd metformina ca monoterapie nu este suficient\u0103 \u0219i rezisten\u021ba la insulin\u0103 este considerat\u0103 un factor major al hiperglicemiei.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Pioglit MF Forte?<\/h2>\n<p>Pioglit MF Forte combin\u0103 dou\u0103 mecanisme complementare care vizeaz\u0103 rezisten\u021ba la insulin\u0103 f\u0103r\u0103 a stimula eliberarea de insulin\u0103:<\/p>\n<ul>\n<li><strong>Metformin\u0103<\/strong> \u2014 activeaz\u0103 AMPK \u00een ficat, reduc\u00e2nd gliconeogeneza hepatic\u0103 cu aproximativ o treime. De asemenea, \u00eembun\u0103t\u0103\u021be\u0219te sensibilitatea periferic\u0103 la insulin\u0103 \u0219i \u00eencetine\u0219te u\u0219or absorb\u021bia intestinal\u0103 de glucoz\u0103.<\/li>\n<li><strong>Pioglitazona<\/strong> \u2014 un agonist PPAR-\u03b3 care \u00eembun\u0103t\u0103\u021be\u0219te sensibilitatea la insulin\u0103 \u00een mu\u0219chi \u0219i \u021besut adipos, deplaseaz\u0103 depozitarea gr\u0103similor de la nivel visceral la subcutanat \u0219i \u00eembun\u0103t\u0103\u021be\u0219te stetoza hepatic\u0103.<\/li>\n<\/ul>\n<p>Deoarece niciunul dintre medicamente nu stimuleaz\u0103 eliberarea de insulin\u0103, combina\u021bia <strong>nu provoac\u0103 hipoglicemie<\/strong> de la sine. Reducerea HbA1c este de obicei <strong>1,5\u20132,0 puncte procentuale<\/strong>. Pioglitazonul \u00eembun\u0103t\u0103\u021be\u0219te \u0219i HDL \u0219i trigliceridele \u0219i poate avea beneficii \u00een boala hepatic\u0103 gras\u0103 non-alcoolic\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrare<\/h2>\n<p><strong>Doza uzual\u0103:<\/strong> o tablet\u0103 o dat\u0103 sau de dou\u0103 ori pe zi cu m\u00e2ncare. Doza ini\u021bial\u0103 este aleas\u0103 pentru a se potrivi cu terapia actual\u0103 a pacientului; titra\u021bi \u00een sus la fiecare 4\u20138 s\u0103pt\u0103m\u00e2ni \u00een func\u021bie de HbA1c \u0219i tolerabilitate. Doza zilnic\u0103 maxim\u0103: pioglitazon 45 mg + metformin\u0103 2.000 mg.<\/p>\n<ul>\n<li><strong>Lua\u021bi cu m\u00e2ncare<\/strong> \u2014 reduce tulbur\u0103rile gastrointestinale cauzate de metformin\u0103.<\/li>\n<li><strong>Acorda\u021bi 8\u201312 s\u0103pt\u0103m\u00e2ni<\/strong> \u00eenainte de a evalua componenta de pioglitazon \u2014 acesta are un \u00eenceput lent.<\/li>\n<li><strong>Doza renal\u0103.<\/strong> Evita\u021bi dac\u0103 eGFR &lt; 30. Reduce\u021bi metformina la jum\u0103tate dac\u0103 eGFR 30\u201345.<\/li>\n<li><strong>Suspendare pentru contrast IV, interven\u021bie chirurgical\u0103 sau boal\u0103 acut\u0103<\/strong> cu deshidratare.<\/li>\n<li>Monitoriza\u021bi periodic greutatea, edemul de glezn\u0103, ALT \u0219i vitamina B12.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Efecte adverse ale metforminei (primele 1\u20132 s\u0103pt\u0103m\u00e2ni):<\/strong> diaree, grea\u021b\u0103, crampe abdominale, gust metalic, flatulen\u021b\u0103. De obicei se amelioraz\u0103 cu timpul sau cu formularea cu eliberare prelungit\u0103.<\/p>\n<p><strong>Efecte adverse ale pioglitazonei:<\/strong><\/p>\n<ul>\n<li>Cre\u0219tere \u00een greutate (2\u20134 kg)<\/li>\n<li>Edem periferic \u2014 cel mai frecvent motiv de \u00eentrerupere<\/li>\n<li>Anemie u\u0219oar\u0103 (hemodilu\u021bie)<\/li>\n<li>Cefalee, mialgii, infec\u021bii ale tractului respirator superior<\/li>\n<li>Rare: decompensare de insuficien\u021b\u0103 cardiac\u0103, semnal de cancer vezical (doze mari pe termen lung), edem macular, fracturi osoase (la femei)<\/li>\n<\/ul>\n<p><strong>Rare dar grave (metformin\u0103):<\/strong> acidoz\u0103 lactic\u0103 \u2014 aproape \u00eentotdeauna \u00een contextul de AKI, septicemie sau hipoxie. Deficien\u021b\u0103 de vitamina B12 la utilizare pe termen lung; verifica\u021bi anual.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Gemfibrozil<\/strong> \u2014 dubleaz\u0103 nivelurile de pioglitazon\u0103; limita\u021bi pioglitazona la 15 mg\/zi.<\/li>\n<li><strong>Rifampicin\u0103<\/strong> \u2014 reduce nivelurile de pioglitazon\u0103.<\/li>\n<li><strong>Mediu de contrast iodat IV<\/strong> \u2014 \u00eentrerupe\u021bi administrarea metforminei (48 de ore post-procedur\u0103 dac\u0103 eGFR &lt; 60).<\/li>\n<li><strong>Insulin\u0103<\/strong> \u2014 reten\u021bie de fluide aditiv\u0103; fi\u021bi aten\u021bi la edem \u0219i insuficien\u021b\u0103 cardiac\u0103.<\/li>\n<li><strong>Sulfoniluree \/ meglitinide \/ insulin\u0103<\/strong> \u2014 cre\u0219te riscul de hipoglicemie (absent la administrarea Pioglit MF Forte singur).<\/li>\n<li><strong>Medicamente cationice<\/strong> (cimetidin\u0103, dolutegravir, ranolazin\u0103) \u2014 cresc nivelurile de metformin\u0103.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cine Nu Ar Trebui s\u0103 ia Pioglit MF Forte?<\/h2>\n<ul>\n<li>Insuficien\u021b\u0103 cardiac\u0103 (NYHA III\u2013IV)<\/li>\n<li>Cancer vezical activ sau antecedente de cancer vezical<\/li>\n<li>Hematurie macroscopic\u0103 inexplicabil\u0103<\/li>\n<li>Insuficien\u021b\u0103 renal\u0103 sever\u0103 (eGFR &lt; 30)<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103 sau ALT &gt; 2,5\u00d7 limita superioar\u0103 normal\u0103<\/li>\n<li>Cetoacidoz\u0103 diabetic\u0103; diabet zaharat tip 1<\/li>\n<li>Boal\u0103 acut\u0103 cu risc de hipoxie tisular\u0103<\/li>\n<li>Sarcin\u0103, al\u0103ptare<\/li>\n<li>Hipersensibilitate cunoscut\u0103 la oricare component\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Pioglit MF Forte la temperaturi sub 30\u00b0C \u00eentr-un loc uscat. Depozita\u021bi \u00een afara reachii copiilor.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Este Pioglit MF Forte acela\u0219i lucru cu luarea metforminei \u0219i pioglitazonei separat?<\/h3>\n<p>Din punct de vedere clinic, da \u2014 acelea\u0219i molecule, acelea\u0219i doze. Combina\u021bia cu doz\u0103 fix\u0103 simplific\u0103 regimul (o tablet\u0103 \u00een loc de dou\u0103), \u00eembun\u0103t\u0103\u021be\u0219te de obicei aderen\u021ba \u0219i este de obicei mai ieftin\u0103 dec\u00e2t cele dou\u0103 componente cump\u0103rate separat.<\/p>\n<h3 class=\"wp-block-heading\">Va provoca Pioglit MF Forte hipoglicemie?<\/h3>\n<p>Nu de la sine \u2014 nici metformina, nici pioglitazona nu stimuleaz\u0103 eliberarea de insulin\u0103. Hipoglicemia devine o problem\u0103 doar atunci c\u00e2nd Pioglit MF Forte este combinat cu o sulfoniluree, meglitinid\u0103 sau insulin\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Cauzeaz\u0103 Pioglit MF Forte cre\u0219tere \u00een greutate?<\/h3>\n<p>Pioglitazona cauzeaz\u0103 o cre\u0219tere \u00een greutate de 2\u20134 kg, par\u021bial compensat\u0103 de efectul neutru sau u\u0219or de reducere a greut\u0103\u021bii al metforminei. Modificarea net\u0103 este de obicei o cre\u0219tere de 1\u20133 kg \u00een primul an.<\/p>\n<h3 class=\"wp-black-heading\">Pot lua Pioglit MF Forte dac\u0103 am ficat gras sau NASH?<\/h3>\n<p>Da \u2014 pioglitazona este unul dintre pu\u021binele medicamente cu dovezi bune \u00een steatohepatita non-alcoolic\u0103 (studiul PIVENS a ar\u0103tat \u00eembun\u0103t\u0103\u021biri histologice). Metformina are dovezi mai limitate specifice NASH, dar este favorabil\u0103 pentru greutate \u0219i reduce produc\u021bia hepatic\u0103 de glucoz\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Ce se \u00eent\u00e2mpl\u0103 dac\u0103 am reten\u021bie u\u0219oar\u0103 de lichide?<\/h3>\n<p>U\u0219oara umfl\u0103tur\u0103 la glezne poate fi uneori gestionat\u0103 prin reducerea dozei sau ad\u0103ugarea unui diuretic. Dificult\u0103\u021bi \u00een respira\u021bie, cre\u0219tere rapid\u0103 \u00een greutate sau edem periferic nou necesit\u0103 evaluare medical\u0103 prompt\u0103 \u2014 poate fi necesar\u0103 \u00eentreruperea pioglitazonei.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 consum alcool \u00een timp ce iau Pioglit MF Forte?<\/h3>\n<p>Consumul moderat de alcool \u00een timpul mesei este de obicei sigur. Evita\u021bi consumul excesiv \u2014 cre\u0219te riscul de acidoz\u0103 lactic\u0103 (metformin\u0103) \u0219i poate afecta func\u021bia hepatic\u0103 (ambele medicamente).<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Pioglit MF Forte online?<\/h3>\n<p>Pute\u021bi comanda Pioglit MF Forte (Pioglitazon\u0103 15 mg + Metformin\u0103 850 mg) de la MedsBase \u00een cutii de 30, 60, 90 sau 180 de comprimate. Livr\u0103m \u00een \u00eentreaga lume, cu ambalaj discret \u0219i stoc autentic certificat WHO-GMP de la produc\u0103tor.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente \u00eenrudite pentru Diabet<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pioz-15\/\">Pioz 15 \u2014 monoterapie cu Pioglitazon\u0103 15 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR \u2014 Metformin cu eliberare prelungit\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/januvia\/\">Januvia \u2014 Sitagliptin\u0103 (inhibitor DPP-4)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin\u0103 (inhibitor SGLT-2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glisen-pm\/\">Glisen PM \u2014 combina\u021bie tripl\u0103 Glimepirid\u0103 + Pioglitazon\u0103 + Metformin\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/diabetes-medication\/\"><strong>Vizualiza\u021bi toate Medicamentele pentru Diabet<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are doar scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat din domeniul s\u0103n\u0103t\u0103\u021bii. Produsele care con\u021bin Pioglitazon\u0103 sunt contraindicate \u00een insuficien\u021b\u0103 cardiac\u0103 \u0219i cancer vezical activ \u2014 utiliza\u021bi \u00eentotdeauna sub \u00eendrumare medical\u0103 cu monitorizare renal\u0103, hepatic\u0103 \u0219i cardiovascular\u0103.<\/div>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Stimuleaz\u0103 secre\u021bia de insulin\u0103<br \/>\n\u2705 Combin\u0103 dou\u0103 medicamente eficiente<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te controlul glicemic<br \/>\n\u2705 Reduce rezisten\u021ba la insulin\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te gestionarea diabetului<\/h5>\n<p><span style=\"color: #999999;\">Pioglit Mf Forte con\u021bine Pioglitazon\u0103 \u0219i Metformin\u0103<\/span><\/p>","protected":false},"featured_media":50754,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[],"class_list":{"0":"post-50753","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","11":"first","12":"outofstock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/50753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=50753"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/50754"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=50753"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=50753"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=50753"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=50753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}